Diagnostic criteria for anxiety and depression
Pro Research Analysisby 
Searched over 200M research papers
Diagnostic Criteria for Anxiety and Depression: DSM-5 and ICD-10 Keywords
DSM-5 Diagnostic Criteria for Depression and Anxiety
The DSM-5 provides specific criteria for diagnosing major depressive disorder (MDD) and generalized anxiety disorder (GAD). For MDD, the criteria include experiencing at least five symptoms such as persistent sadness, loss of interest, changes in appetite or sleep, fatigue, feelings of worthlessness, and difficulty concentrating, with at least one symptom being either depressed mood or loss of interest, present for at least two weeks. For GAD, the criteria require excessive anxiety and worry occurring more days than not for at least six months, about various activities, and difficulty controlling the worry, along with symptoms like restlessness, fatigue, irritability, muscle tension, and sleep disturbance 134.
ICD-10 and Mixed Anxiety and Depression
The ICD-10 introduces a category called Mixed Anxiety and Depression (MAD), which is used mainly in primary care. This diagnosis is for patients who have symptoms of both anxiety and depression of limited and equal intensity, with some autonomic features, but who do not meet the full criteria for either disorder individually. The validity of this category is still under investigation, and it is recognized that many patients may present with overlapping symptoms that do not fit neatly into one category .
Symptom-Based and Self-Reported Diagnostic Measures
Symptom-based diagnostic tools use structured questionnaires that map directly onto DSM-5 criteria, while self-reported measures rely on individuals’ reports of prior professional diagnoses. Studies show moderate agreement between these two approaches for MDD and GAD, but less agreement for phobic disorders. Symptom-based methods tend to distribute anxiety diagnoses more evenly across subtypes, while self-reported diagnoses often cluster under GAD. Both methods require further validation against gold-standard clinical interviews .
Screening Tools and Dimensional Assessment
Several validated screening tools are used to assess depression and anxiety based on DSM-5 criteria. The Hospital Anxiety and Depression Scale (HADS) and the Inventory of Depression and Anxiety Symptoms (IDAS) are widely used. These tools provide cutoff scores for screening, efficiency, and diagnostic confirmation, and can classify symptom severity as mild, moderate, or severe. The IDAS, for example, offers dimensional assessment and is effective in predicting DSM-5 diagnoses 12. The DSM-5 Anxious Distress Specifier Interview (DADSI) is another tool that measures anxiety severity in patients with depression and is found to be as valid as the Hamilton Anxiety Scale (HAMA), but is briefer and more feasible for clinical use .
Differential Diagnosis and Comorbidity
Anxiety and depression frequently coexist, and their relationship can be complex. Differential diagnosis should consider whether depression is secondary to anxiety, anxiety is a residual component of depression, or both conditions are present as a mixed syndrome. Clinimetric criteria and clinical judgment are important for distinguishing between these presentations and guiding treatment . Studies also suggest that empirical classification models that include both symptoms and disability measures can identify distinct cross-diagnostic subtypes, highlighting the need for broader diagnostic approaches .
Objective and Machine Learning-Based Diagnostic Approaches
Recent research explores the use of cognitive-behavioral task batteries and machine learning algorithms to differentiate between anxiety and depression. These methods analyze patterns in cognitive biases and performance to support diagnosis, offering increased specificity and objectivity compared to self-report measures. Such tools can complement clinical interviews and provide individualized profiles for more tailored treatment 78.
Conclusion
The diagnostic criteria for anxiety and depression are primarily based on DSM-5 and ICD-10 guidelines, which specify symptom duration, severity, and functional impact. Screening tools like HADS and IDAS, as well as structured interviews, are commonly used to assess these disorders. The overlap and comorbidity between anxiety and depression require careful differential diagnosis, often supported by clinimetric and objective assessment tools. Emerging machine learning approaches offer promise for more precise and individualized diagnosis, but clinical judgment remains essential for accurate assessment and treatment planning.
Sources and full results
Most relevant research papers on this topic